Loading stock data...
Last Updated: 10 Mar 2026, 03:15:00 PM (IST)

Gujarat Inject (Kerala) Ltd.

BSE: GUJINJEC

BSE
68.50 1.00 (1.48%)

Prev Close

67.5

Open Price

68

Volume

54,844

Today Low / High

68 / 68.55

52 WK Low / High

17.02 / 68.55

Range

65 - 72

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 68.5, reflecting a change of 1 (1.48148%). The expected target range on the BSE is 65 - 72. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.

Gujarat Inject (Kerala) Ltd. Graph

Gujarat Inject (Kerala) Ltd. Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Gujarat Inject (Kerala) Ltd. T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 68.50, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 68.50 69.19 62.27 - 76.10
69.87 55.90 - 83.84
70.56 49.39 - 91.72
Bearish Scenario 68.50 67.82 61.03 - 74.60
67.13 53.70 - 80.56
66.45 46.51 - 86.38

Overview of Gujarat Inject (Kerala) Ltd.

ISIN

INE659F01014

Industry

Medical - Distribution

Vol.Avg

64,320

Market Cap

933,873,750

Last Dividend

0

Official Website

Visit Website

IPO Date

2008-01-01

DCF Diff

16.98

DCF

-1

Financial Ratios Every Investor Needs

Stock Rating Details for GUJINJEC

Metric Value Recommendation
Overall Rating C+ Sell
DCF Score 1 Strong Sell
ROE Score 3 Neutral
ROA Score 4 Buy
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 3 Neutral

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 19.05 Cr 17.78 Cr 1.27 Cr 0.0666 0.00 Cr 0.00 Cr 1.08 Cr 1.02 Cr 0.67 1.26 Cr 0.0534
2024-03-31 5.79 Cr 5.40 Cr 0.39 Cr 0.0666 0.00 Cr 0.30 Cr 0.04 Cr 0.08 Cr 0.07 0.11 Cr 0.0143
2023-03-31 0.17 Cr 0.15 Cr 0.02 Cr 0.1146 0.00 Cr 0.37 Cr -0.38 Cr 0.04 Cr 0.05 0.06 Cr 0.2362
2022-03-31 0.02 Cr 0.02 Cr 0.01 Cr 0.3131 0.00 Cr 0.04 Cr -0.05 Cr 0.00 Cr 0.00 0.00 Cr 0.0978
2021-03-31 0.01 Cr 0.01 Cr 0.00 Cr 0.2278 0.00 Cr 0.11 Cr -0.11 Cr -0.11 Cr -0.21 -0.11 Cr -9.1082

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 0.03 Cr 11.95 Cr 1.94 Cr 10.0124 Cr 0.00 Cr -0.03 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 1.9381 Cr
2024-03-31 2.92 Cr 8.69 Cr 0.14 Cr 8.5453 Cr 0.00 Cr -2.92 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.1400 Cr
2023-03-31 0.06 Cr 0.30 Cr 1.14 Cr 482.7578 Cr 0.61 Cr 0.55 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.7255 Cr
2022-03-31 0.01 Cr 0.06 Cr 0.94 Cr 482.7167 Cr 0.73 Cr 0.73 Cr 0.01 Cr 0.00 Cr 0.00 Cr 0.00 Cr -0.01 Cr 0.5281 Cr
2021-03-31 0.01 Cr 0.02 Cr 0.90 Cr -0.8807 Cr 0.69 Cr 0.68 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.4831 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 -3.5220 Cr 0.0000 Cr 0.6292 Cr -3.5220 Cr -2.8928 Cr 0.0263 Cr 0.0000 Cr 1.2541 Cr 0.0000 Cr 0.0000 Cr 0.0000 Cr
2024-03-31 -6.0276 Cr 0.0003 Cr 8.8848 Cr -6.0276 Cr 2.8575 Cr 2.9192 Cr 0.0000 Cr 0.1053 Cr -0.4152 Cr 0.0000 Cr 0.0000 Cr
2023-03-31 0.0526 Cr 0.0016 Cr 0.0000 Cr 0.0526 Cr 0.0542 Cr 0.0617 Cr 0.0000 Cr 0.0554 Cr 0.0000 Cr 0.0000 Cr 0.0089 Cr
2022-03-31 -0.0010 Cr 0.0000 Cr 0.0000 Cr -0.0010 Cr -0.0010 Cr 0.0075 Cr 0.0000 Cr -10.5248 Cr 0.0000 Cr -0.0007 Cr -0.0058 Cr
2021-03-31 -0.1068 Cr 0.0000 Cr 0.1027 Cr -0.1068 Cr -0.0041 Cr 0.0085 Cr 0.0000 Cr -0.1052 Cr 0.1027 Cr 0.0000 Cr -0.0031 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-09-30 1.58 Cr 1.52 Cr 0.06 Cr 0.0356 0.03 Cr 0.07 Cr 0.05 0.09 Cr 0.0428
2025-06-30 2.42 Cr 2.26 Cr 0.16 Cr 0.0672 0.10 Cr 0.07 Cr 0.05 0.10 Cr 0.0304
2025-03-31 4.24 Cr 4.12 Cr 0.12 Cr 0.0278 0.09 Cr 0.07 Cr 0.05 0.10 Cr 0.0173
2024-12-31 3.15 Cr 2.85 Cr 0.30 Cr 0.0956 0.28 Cr 0.21 Cr 0.14 0.28 Cr 0.0671
2024-09-30 8.61 Cr 8.04 Cr 0.57 Cr 0.0661 0.54 Cr 0.61 Cr 0.42 0.71 Cr 0.0709

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-09-30 0.23 Cr 0.00 Cr 0.23 Cr 7.04 Cr 0.00 Cr 7.28 Cr 0.00 Cr 11.70 Cr 1.54 Cr
2025-03-31 0.03 Cr 0.00 Cr 0.03 Cr 9.13 Cr 0.00 Cr 9.16 Cr 0.00 Cr 11.95 Cr 1.94 Cr
2024-09-30 0.15 Cr 0.00 Cr 0.15 Cr 0.00 Cr 0.00 Cr 14.23 Cr 0.00 Cr 14.23 Cr 4.50 Cr
2024-03-31 2.92 Cr 0.00 Cr 2.92 Cr 0.03 Cr 0.00 Cr 5.71 Cr 0.00 Cr 8.69 Cr 0.14 Cr
2023-09-30 0.05 Cr 0.00 Cr 0.05 Cr 0.00 Cr 0.00 Cr 0.36 Cr 0.00 Cr 0.36 Cr 1.16 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
No quarterly financial cash flow statement data available.

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Medical - Distribution

Company Name Symbol Price Market Cap Volume
Entero Healthcare Solutions Limited ENTERO ₹1,033.50 ₹44,968,553,390.00 ₹90,891.00

Key Executives

Chief Financial Officer & Executive Director
Deepak Diwan Bachwani

Gender: male

Year Born: 1979

MD, Chairman & Whole-Time Director
Murli Shivshankaran Nair

Gender: male

Year Born: 1969

Company Secretary & Compliance Officer
Manmeetkaur Harshdeepsingh Bhatia

Gender: female

Year Born: 1992

FAQs about Gujarat Inject (Kerala) Ltd.

Who is the CEO of the company?

The CEO is Murli Shivshankaran Nair.

What is the current market price of the stock?

The current price is ₹63.75.

What is the 52-week price range?

The range is ₹17.02-64.7.

What is the market capitalization of the company?

The market capitalization is ₹93.39 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 202.12.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Gujarat Inject (Kerala) Ltd. (ISIN: INE659F01014) is a leading Medical - Distribution in India. With a market capitalization of ₹93.39 crores and an average daily volume of 64,320 shares, it operates in the Medical - Distribution. The company last declared a dividend of ₹0.